Please Wait...

About Financial Lifecycle Solutions

Bioclinica Financial Lifecycle Solutions, formerly Clinverse, Inc., manages the global automation and financial management of clinical trials. As the architect of the industry's first fully automated financial management technology solution for clinical trials, we understand the complexities and unique challenges of global clinical trials. We continue to aggressively invest in the financial services that meet the pain points within the clinical trial industry.

With our proprietary transaction engine, ClinPay, we are able to manage any term negotiated in a clinical trial agreement and are capable of converting more than 140 currencies in more than 220 countries. As a secure online clinical trial payment network, ClinPay dramatically reduces time spent on the investigator payment process and significantly increases clinical trial productivity.

With our budget management and cash forecasting solution, ClinPlan, sponsors and CROs can efficiently and frequently assess trial expense needs based on activities such as site and subject enrollment in order to proactively plan for needed ongoing expenses of a clinical trial.

Our patient reimbursement solution, ClinDebit, eliminates the need for site accounting, reduces costs and transactional fees and makes payments directly to subjects. As a result of these solutions, sponsors, CROs and investigators gain greater control and visibility, as well as a great deal more time for clinical trial management.

Used by leading sponsors and CROs, our solutions allow our clients to benefit from reduced workload, time and costs achieved through automation and unprecedented transparency and workflow.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @SchulmanIRB: #FDA final rule requires #medicaldevice #research conducted outside US to conform with GCP standards | via @RAPSorg https:…
bioclinica (14 hours ago)
RT @manchempharma: Paul Brooks, Executive Director, @RAPSorg comments on Brexit and the operational trade and regulatory environment affect…
bioclinica (14 hours ago)
RT @eClinical_Jen: Clinical Data Management articles available on SCDM Website - While all articles are available to members, there are sel…
bioclinica (14 hours ago)
Live from Las Vegas where Bioclinica's Research Development Director Marieke Cajal, PhD, is presenting on site star… https://t.co/lVglg6NWdV
bioclinica (15 hours ago)
Many thanks all who attended @bioclinica's Executive Roundtable on Safety Mgmt for Pharma Cos in Japan in Tokyo th… https://t.co/OzHeSvHTUk
bioclinica (15 hours ago)
RT @bioclinica: @CardiacSafety Consortium needs your feedback! Help make the upcoming think tank "Evaluation of #MobileTechnologies in #CV…
bioclinica (17 hours ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen